Skip to main content
. 2021 Jun 4;11(6):508. doi: 10.3390/jpm11060508

Figure 1.

Figure 1

Associations of miR-223-3p (amol/µL) and the miR-126-3p to miR-223-3p ratio with the occurrences of clinical endpoints within 30 days and one year. (A) MiR-223-3p (amol/µL), normalized using miR-423-3p and miR-150-5p, as a predictor of endpoints. (B) MiR-126-3p (amol/µL) to miR-223-3p (amol/µL) ratio as a predictor of endpoints.